In  ||| S:0 E:3 ||| IN
vivo  ||| S:3 E:8 ||| JJ
behavior  ||| S:8 E:17 ||| NN
of  ||| S:17 E:20 ||| IN
surface  ||| S:20 E:28 ||| NN
modified  ||| S:28 E:37 ||| VBN
Ti6Al7Nb  ||| S:37 E:46 ||| CD
alloys  ||| S:46 E:53 ||| NNS
used  ||| S:53 E:58 ||| VBN
in  ||| S:58 E:61 ||| IN
selective  ||| S:61 E:71 ||| JJ
laser  ||| S:71 E:77 ||| NN
melting  ||| S:77 E:85 ||| NN
for  ||| S:85 E:89 ||| IN
custom-made  ||| S:89 E:101 ||| JJ
implants ||| S:101 E:109 ||| NN
.  ||| S:109 E:111 ||| .
A  ||| S:111 E:113 ||| DT
preliminary  ||| S:113 E:125 ||| JJ
study  ||| S:125 E:131 ||| NN
The  ||| S:131 E:135 ||| DT
objectives  ||| S:135 E:146 ||| NNS
of  ||| S:146 E:149 ||| IN
this  ||| S:149 E:154 ||| DT
study  ||| S:154 E:160 ||| NN
were  ||| S:160 E:165 ||| VBD
to  ||| S:165 E:168 ||| TO
test  ||| S:168 E:173 ||| VB
the  ||| S:173 E:177 ||| DT
biocompatibility  ||| S:177 E:194 ||| NN
and  ||| S:194 E:198 ||| CC
to  ||| S:198 E:201 ||| TO
evaluate  ||| S:201 E:210 ||| VB
the  ||| S:210 E:214 ||| DT
osseointegration  ||| S:214 E:231 ||| NN
of  ||| S:231 E:234 ||| IN
Titanium-Aluminum-Niobium  ||| S:234 E:260 ||| NNP
( ||| S:260 E:261 ||| -LRB-
Ti6Al7Nb ||| S:261 E:269 ||| NNP
)  ||| S:269 E:271 ||| -RRB-
alloy  ||| S:271 E:277 ||| VBZ
used  ||| S:277 E:282 ||| VBN
in  ||| S:282 E:285 ||| IN
the  ||| S:285 E:289 ||| DT
manufacturing  ||| S:289 E:303 ||| NN
of  ||| S:303 E:306 ||| IN
personalized  ||| S:306 E:319 ||| JJ
implants  ||| S:319 E:328 ||| NN
with  ||| S:328 E:333 ||| IN
selective  ||| S:333 E:343 ||| JJ
laser  ||| S:343 E:349 ||| NN
melting  ||| S:349 E:357 ||| NNS
( ||| S:357 E:358 ||| -LRB-
SLM ||| S:358 E:361 ||| NNP
)  ||| S:361 E:363 ||| -RRB-
technology  ||| S:363 E:374 ||| NN
and  ||| S:374 E:378 ||| CC
to  ||| S:378 E:381 ||| TO
compare  ||| S:381 E:389 ||| VB
the  ||| S:389 E:393 ||| DT
growth  ||| S:393 E:400 ||| NN
viability  ||| S:400 E:410 ||| NN
of  ||| S:410 E:413 ||| IN
osteoblastic-like  ||| S:413 E:431 ||| JJ
cells  ||| S:431 E:437 ||| NNS
on  ||| S:437 E:440 ||| IN
different  ||| S:440 E:450 ||| JJ
Ti6Al7Nb  ||| S:450 E:459 ||| CD
alloy  ||| S:459 E:465 ||| CD
samples  ||| S:465 E:473 ||| NNS
( ||| S:473 E:474 ||| -LRB-
plain ||| S:474 E:479 ||| RB
,  ||| S:479 E:481 ||| ,
coated  ||| S:481 E:488 ||| VBN
with  ||| S:488 E:493 ||| IN
hydroxyapatite  ||| S:493 E:508 ||| NN
or  ||| S:508 E:511 ||| CC
SiO2-TiO2 ||| S:511 E:520 ||| CD
)  ||| S:520 E:522 ||| -RRB-
implanted  ||| S:522 E:532 ||| VBD
into  ||| S:532 E:537 ||| IN
the  ||| S:537 E:541 ||| DT
cranial  ||| S:541 E:549 ||| JJ
bone  ||| S:549 E:554 ||| NN
of  ||| S:554 E:557 ||| IN
Wistar  ||| S:557 E:564 ||| NNP
rats ||| S:564 E:568 ||| NNS
.  ||| S:568 E:570 ||| .
In  ||| S:570 E:573 ||| IN
terms  ||| S:573 E:579 ||| NNS
of  ||| S:579 E:582 ||| IN
biocompatibility ||| S:582 E:598 ||| NN
,  ||| S:598 E:600 ||| ,
the  ||| S:600 E:604 ||| DT
cone-beam  ||| S:604 E:614 ||| JJ
computer-tomography  ||| S:614 E:634 ||| JJ
head  ||| S:634 E:639 ||| NN
scans  ||| S:639 E:645 ||| VBZ
taken  ||| S:645 E:651 ||| VBN
at  ||| S:651 E:654 ||| IN
the  ||| S:654 E:658 ||| DT
moment  ||| S:658 E:665 ||| NN
of  ||| S:665 E:668 ||| IN
sacrifice  ||| S:668 E:678 ||| NN
of  ||| S:678 E:681 ||| IN
each  ||| S:681 E:686 ||| DT
group  ||| S:686 E:692 ||| NN
( ||| S:692 E:693 ||| -LRB-
one ||| S:693 E:696 ||| CD
,  ||| S:696 E:698 ||| ,
two  ||| S:698 E:702 ||| CD
and  ||| S:702 E:706 ||| CC
three  ||| S:706 E:712 ||| CD
months ||| S:712 E:718 ||| NNS
)  ||| S:718 E:720 ||| -RRB-
showed  ||| S:720 E:727 ||| VBD
no  ||| S:727 E:730 ||| DT
implant  ||| S:730 E:738 ||| JJ
displacement ||| S:738 E:750 ||| NN
,  ||| S:750 E:752 ||| ,
no  ||| S:752 E:755 ||| DT
osteolysis  ||| S:755 E:766 ||| NN
and  ||| S:766 E:770 ||| CC
no  ||| S:770 E:773 ||| DT
liquid  ||| S:773 E:780 ||| JJ
collection  ||| S:780 E:791 ||| NN
around  ||| S:791 E:798 ||| IN
the  ||| S:798 E:802 ||| DT
implants ||| S:802 E:810 ||| NN
.  ||| S:810 E:812 ||| .
At  ||| S:812 E:815 ||| IN
one  ||| S:815 E:819 ||| CD
month ||| S:819 E:824 ||| NN
,  ||| S:824 E:826 ||| ,
around  ||| S:826 E:833 ||| IN
all  ||| S:833 E:837 ||| DT
types  ||| S:837 E:843 ||| NNS
of  ||| S:843 E:846 ||| IN
implants  ||| S:846 E:855 ||| JJ
new  ||| S:855 E:859 ||| JJ
bone  ||| S:859 E:864 ||| NN
formation  ||| S:864 E:874 ||| NN
was  ||| S:874 E:878 ||| VBD
noticed ||| S:878 E:885 ||| VBN
,  ||| S:885 E:887 ||| ,
although  ||| S:887 E:896 ||| IN
around  ||| S:896 E:903 ||| IN
the  ||| S:903 E:907 ||| DT
plain  ||| S:907 E:913 ||| JJ
Ti6Al7Nb  ||| S:913 E:922 ||| NN
implant  ||| S:922 E:930 ||| VBD
a  ||| S:930 E:932 ||| DT
large  ||| S:932 E:938 ||| JJ
amount  ||| S:938 E:945 ||| NN
of  ||| S:945 E:948 ||| IN
powder  ||| S:948 E:955 ||| JJ
debris  ||| S:955 E:962 ||| NN
was  ||| S:962 E:966 ||| VBD
present ||| S:966 E:973 ||| JJ
.  ||| S:973 E:975 ||| .
Still ||| S:975 E:980 ||| RB
,  ||| S:980 E:982 ||| ,
no  ||| S:982 E:985 ||| DT
inflammatory  ||| S:985 E:998 ||| JJ
reaction  ||| S:998 E:1007 ||| NN
was  ||| S:1007 E:1011 ||| VBD
seen ||| S:1011 E:1015 ||| VBN
.  ||| S:1015 E:1017 ||| .
At  ||| S:1017 E:1020 ||| IN
two  ||| S:1020 E:1024 ||| CD
months ||| S:1024 E:1030 ||| NNS
,  ||| S:1030 E:1032 ||| ,
the  ||| S:1032 E:1036 ||| DT
distance  ||| S:1036 E:1045 ||| NN
between  ||| S:1045 E:1053 ||| IN
the  ||| S:1053 E:1057 ||| DT
implants  ||| S:1057 E:1066 ||| NN
and  ||| S:1066 E:1070 ||| CC
the  ||| S:1070 E:1074 ||| DT
calvarial  ||| S:1074 E:1084 ||| JJ
bone  ||| S:1084 E:1089 ||| NN
margins  ||| S:1089 E:1097 ||| NNS
diminished ||| S:1097 E:1107 ||| VBN
.  ||| S:1107 E:1109 ||| .
A  ||| S:1109 E:1111 ||| DT
thin  ||| S:1111 E:1116 ||| JJ
layer  ||| S:1116 E:1122 ||| NN
of  ||| S:1122 E:1125 ||| IN
fibrous  ||| S:1125 E:1133 ||| JJ
tissue  ||| S:1133 E:1140 ||| NN
was  ||| S:1140 E:1144 ||| VBD
noticed  ||| S:1144 E:1152 ||| VBN
around  ||| S:1152 E:1159 ||| IN
the  ||| S:1159 E:1163 ||| DT
Ti6Al7Nb  ||| S:1163 E:1172 ||| NNP
implant  ||| S:1172 E:1180 ||| VBD
coated  ||| S:1180 E:1187 ||| VBN
with  ||| S:1187 E:1192 ||| IN
hydroxyapatite  ||| S:1192 E:1207 ||| NN
but  ||| S:1207 E:1211 ||| CC
no  ||| S:1211 E:1214 ||| DT
bone  ||| S:1214 E:1219 ||| NN
contact  ||| S:1219 E:1227 ||| NN
was  ||| S:1227 E:1231 ||| VBD
achieved ||| S:1231 E:1239 ||| VBN
.  ||| S:1239 E:1241 ||| .
In  ||| S:1241 E:1244 ||| IN
the  ||| S:1244 E:1248 ||| DT
group  ||| S:1248 E:1254 ||| NN
sacrificed  ||| S:1254 E:1265 ||| NN
at  ||| S:1265 E:1268 ||| IN
three  ||| S:1268 E:1274 ||| CD
months  ||| S:1274 E:1281 ||| NNS
there  ||| S:1281 E:1287 ||| EX
was  ||| S:1287 E:1291 ||| VBD
still  ||| S:1291 E:1297 ||| RB
no  ||| S:1297 E:1300 ||| DT
bone  ||| S:1300 E:1305 ||| NN
contact ||| S:1305 E:1312 ||| NN
,  ||| S:1312 E:1314 ||| ,
but  ||| S:1314 E:1318 ||| CC
noticeable  ||| S:1318 E:1329 ||| NNS
were  ||| S:1329 E:1334 ||| VBD
the  ||| S:1334 E:1338 ||| DT
SiO2-TiO2 ||| S:1338 E:1347 ||| NN
.  ||| S:1347 E:1349 ||| .
In  ||| S:1349 E:1352 ||| IN
the  ||| S:1352 E:1356 ||| DT
group  ||| S:1356 E:1362 ||| NN
sacrificed  ||| S:1362 E:1373 ||| NN
at  ||| S:1373 E:1376 ||| IN
three  ||| S:1376 E:1382 ||| CD
months  ||| S:1382 E:1389 ||| NNS
SiO2-TiO2  ||| S:1389 E:1399 ||| VBP
particles  ||| S:1399 E:1409 ||| VBN
detached  ||| S:1409 E:1418 ||| VBN
from  ||| S:1418 E:1423 ||| IN
the  ||| S:1423 E:1427 ||| DT
implant  ||| S:1427 E:1435 ||| NN
and  ||| S:1435 E:1439 ||| CC
completely  ||| S:1439 E:1450 ||| RB
integrated  ||| S:1450 E:1461 ||| VBN
in  ||| S:1461 E:1464 ||| IN
the  ||| S:1464 E:1468 ||| DT
tissue  ||| S:1468 E:1475 ||| NN
were  ||| S:1475 E:1480 ||| VBD
noticeable ||| S:1480 E:1490 ||| VBN
.  ||| S:1490 E:1492 ||| .
All  ||| S:1492 E:1496 ||| DT
results  ||| S:1496 E:1504 ||| NNS
suggested  ||| S:1504 E:1514 ||| VBD
that  ||| S:1514 E:1519 ||| IN
the  ||| S:1519 E:1523 ||| DT
Ti6Al7Nb  ||| S:1523 E:1532 ||| JJ
alloy  ||| S:1532 E:1538 ||| NN
with  ||| S:1538 E:1543 ||| IN
or  ||| S:1543 E:1546 ||| CC
without  ||| S:1546 E:1554 ||| IN
infiltration  ||| S:1554 E:1567 ||| NN
is  ||| S:1567 E:1570 ||| VBZ
well  ||| S:1570 E:1575 ||| RB
biologically  ||| S:1575 E:1588 ||| JJ
tolerated ||| S:1588 E:1597 ||| NN
.  ||| S:1597 E:1599 ||| .
